Depression News and Research

Latest Depression News and Research

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

Obecure Ltd., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., has received notice of allowance from the US Patent Office for its two key patent applications covering methods of use and compositions covering the use of betahistine with olanzapine for the mitigation of the serious weight gain associated as a side effect of the antipsychotic drug.

23 Feb 2010

Role of behavioral health in pediatric IBD: NIHCD awards $500,000 grant to further study

The National Institutes of Health has awarded a two-year development grant to researchers with Hasbro Children's Hospital and the Bradley Hasbro Children's Research Center to better understand the role behavioral health plays in pediatric inflammatory bowel disease (IBD), a condition that causes chronic and painful inflammation in the gastrointestinal tract.

23 Feb 2010

Nation-wide study to assess risk of suicide among men

The introduction of prostate-specific antigen (PSA) testing as a screening tool for early detection of prostate cancer (PCa) in the beginning of the 1990s drastically increased the detection of PCa. The risk of suicide is increased among cancer patients including men with PCa.

23 Feb 2010

ResMed launches S9 sleep apnoea therapy platform in Europe

ResMed, a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment, today introduced its new cutting-edge sleep apnoea therapy platform called the S9 Series in Europe. The S9 Series combines a sleek design with superior functionality and more comfort. Combined climate control and humidification delivers unsurpassed comfort to the patient by controlling both the temperature and humidity that the patient breathes.

From ResMed Corp 22 Feb 2010

HHMI investigator to discuss how brain creates and controls emotions

Scientists know little about how the brain creates and controls emotions - an uncertainty that presents a major obstacle in the effort to develop treatments for emotional disorders. "The study of the brain science of emotion is in its infancy," says Howard Hughes Medical Institute (HHMI) investigator David Anderson, "yet emotional and psychiatric disorders continue to take an enormous toll on human society."

22 Feb 2010

Brain and tissue sample repository to help advance understanding and treatment of psychiatric diseases

Johns Hopkins Children's Center neurovirologist Robert Yolken, M.D., and collaborators from the Stanley Medical Research Institute have developed a large repository of brain and tissue samples to advance the understanding and treatment of bipolar disorder, major depression and schizophrenia.

20 Feb 2010

Study reveals underrepresentation of women in cardiovascular clinical trials

Women are substantially underrepresented in clinical trials used to formulate women's guidelines and are affected more than men by low social support after a heart attack, according to two studies in the women-themed issue of Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

20 Feb 2010

First Physicians Capital Group's first fiscal quarter Net Revenue from Services rises 32%

First Physicians Capital Group, Inc., an operator of healthcare services firms primarily in rural and suburban markets in the U.S., reported results for the Company’s first fiscal quarter ended December 31, 2009 and delivered today the following update to shareholders from FPCG’s CEO, David Hirschhorn.

19 Feb 2010

PsychoGenics announces alliance with experimental neuropharmacology expert for specialized microdialysis services

PsychoGenics Inc. today announced the establishment of an exclusive alliance with Dr. Jan Kehr, an internationally recognized expert in experimental neuropharmacology, to provide specialized microdialysis services to complement PsychoGenics’ in vivo testing capabilities.

19 Feb 2010

Study shows prevalence of depression among low-income urban mothers

More than half of low-income urban mothers met the criteria for a diagnosis of depression at some point between two weeks and 14 months after giving birth, according to a study led by University of Rochester Medical Center researchers and published online by the journal Pediatrics.

19 Feb 2010

FDA accepts filing of Jazz Pharmaceuticals' NDA for sodium oxybate

Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has accepted for filing the New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia.

19 Feb 2010

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

On the first anniversary of the American Recovery and Reinvestment Act (ARRA) - the economic stimulus - the nation's research universities today provided nearly 100 examples of how a relatively small element of the measure is paying outsize short- and long-term dividends for the nation. Of the $787 billion contained in the ARRA, $21.5 billion is allocated for research and science infrastructure.

18 Feb 2010

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet “Quad” regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

18 Feb 2010

Mental illness associated with more lost work days than any other chronic condition: Study

With mental illness associated with more lost work days than any other chronic condition and costing $17.7 billion annually in lost productivity, understanding its underpinnings is increasingly important to the Canadian economy. Now new research from the Centre for Addiction and Mental Health (CAMH) indicates that the strongest predictor for work disability leaves is a person's past history of occurrences.

18 Feb 2010

NAMI launches new health education program to promote sound "mind and body" health

The National Alliance on Mental Illness (NAMI) has launched a new health education program to promote sound "mind and body" health practices among individuals who live with serious mental illness.

18 Feb 2010

Cyberonics approves new share repurchase program

Cyberonics, Inc. today announced that its board of directors has approved a new share repurchase program. The company's board of directors had previously authorized a repurchase of up to 1.0 million shares, of which a total of 515,000 shares were repurchased.

18 Feb 2010

Review: Giving employees more flexibility over their work schedules likely to boost their health

A new evidence review suggests that giving employees more flexibility over their work schedules is likely to boost their health as judged by measures like blood pressure and stress. But interventions that are motivated or dictated by the needs of the employer, such as cutting hours, either have no effect on employee health or make it worse.

18 Feb 2010

People who are happy and content are less likely to develop heart disease

People who are usually happy, enthusiastic and content are less likely to develop heart disease than those who tend not to be happy, according to a major new study published today (Thursday 18 February).

18 Feb 2010

Javelin Pharmaceuticals’ Dyloject NDA receives FDA PDUFA date

Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dyloject™ (diclofenac sodium) Injection, has received an FDA PDUFA date of October 3, 2010. This NDA review is in support of US marketing approval and registration of Dyloject for the management of acute moderate-to-severe pain in adults.

18 Feb 2010

Carriage Services reports record $45.1M total revenue for fourth-quarter 2009

Carriage Services, Inc. today announced results for the fourth quarter and year ended December 31, 2009.

17 Feb 2010

Depression News and Research

Latest Depression News and Research

Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain

Role of behavioral health in pediatric IBD: NIHCD awards $500,000 grant to further study

Nation-wide study to assess risk of suicide among men

ResMed launches S9 sleep apnoea therapy platform in Europe

HHMI investigator to discuss how brain creates and controls emotions

Brain and tissue sample repository to help advance understanding and treatment of psychiatric diseases

Study reveals underrepresentation of women in cardiovascular clinical trials

First Physicians Capital Group's first fiscal quarter Net Revenue from Services rises 32%

PsychoGenics announces alliance with experimental neuropharmacology expert for specialized microdialysis services

Study shows prevalence of depression among low-income urban mothers

FDA accepts filing of Jazz Pharmaceuticals' NDA for sodium oxybate

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Mental illness associated with more lost work days than any other chronic condition: Study

NAMI launches new health education program to promote sound "mind and body" health

Cyberonics approves new share repurchase program

Review: Giving employees more flexibility over their work schedules likely to boost their health

People who are happy and content are less likely to develop heart disease

Javelin Pharmaceuticals’ Dyloject NDA receives FDA PDUFA date

Carriage Services reports record $45.1M total revenue for fourth-quarter 2009

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Depression News and Research

Latest Depression News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in